-
Innovation Ranking
Innovation Ranking – Lantheus Holdings Inc
Lantheus Holdings Inc (Lantheus), a subsidiary of DuPont de Nemours Inc, carries out the development, manufacturing, sale and distribution of diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases. The company offers products such as DEFINITY, VIALMIX, TechneLite, Xenon-133, NEUROLITE, Cardiolite, Gallium-68, and ABLAVAR. It offers its products in the therapeutic area of oncology, urology, nuclear medicine, cardiology, sonography and radiology among others. The company caters to hospitals, independent diagnostic testing facilities,...
-
Sector Analysis
NewContrast Agents Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Contrast Agents Market Report Overview The contrast agents market size was $3.41 billion in 2023. Factors such as the rising prevalence of chronic diseases and the increased demand for cost-effective and quality healthcare will drive the market growth at a CAGR of more than 2% from 2023 to 2033. Contrast agents are used in radiology to get clearer visualizations of various medical conditions and pathologies. These agents are used with computed tomography (CT), magnetic resonance imaging (MRI), and ultrasounds, among...
-
Sector Analysis
NewNuclear Imaging Agents Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033
Nuclear Imaging Agents Market Report Overview The nuclear imaging agents market size was $988 million in 2023 and will grow at a CAGR of more than 2% from 2023 to 2033. Nuclear imaging is a non-invasive medical technique that uses radioactive tracers (generally F-18 Fluorodeoxyglucose) to assess and diagnose bodily functions and diseases. The diseases include cancers, cardiac diseases, gastrointestinal, endocrine, and neurological diseases. Nuclear Imaging Agents Market Outlook 2023-2033 ($ Million) Buy the Full Report for More Insights into...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – LBL-007 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - LBL-007 in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. LBL-007 in Non-Small Cell Lung Cancer Drug Details: LBL-007...
-
Thematic Analysis
NewState of the Biopharmaceutical Industry 2024 Edition (Mid-Year Update) – Thematic Intelligence
Reasons to buy the ‘State of the Biopharmaceutical Industry 2024’ thematic intelligence report: Highlight the business environment and the industry, regulatory, and macroeconomic trends that are going to shape the biopharmaceutical industry in the next 12 months. Benchmark the impact of major themes on the biopharmaceutical industry in the next 12 months, Identify themes that will have the greatest positive or negative impact in the coming months. Comprehend the opinions of industry respondents on these themes. Predict the industry’s growth prospects...
-
Company Insights
Innovation and Patenting activity of Lantheus Holdings Inc Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Lantheus Holdings Inc Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
Contrast Agents Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Contrast Agents Pipeline Market Report Overview The Contrast Agents pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments ·       Positron Emitting Tomography Contrast Agents ·       Magnetic Resonance Imaging (MRI) Contrast Agents ·       Gadolinium-based MRI Contrast Agents...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Iobenguane I 131 in Neuroblastoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Iobenguane I 131 in Neuroblastoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Iobenguane I 131 in Neuroblastoma Drug Details:Iobenguane I 131 (Azedra) is a...
-
Product Insights
Sweden Nuclear Imaging Agents Market Share
Nuclear Imaging Agents (Diagnostic Imaging) Sweden Market Share report provides quantitative market trends within the Diagnostic Imaging therapeutic area. Robust methodologies ensure an accurate overview of the market to deliver a comprehensive and precise market analysis. It incorporates primary sources from both the demand and supply sides. This is an on-demand report that will be delivered upon request. The report will be delivered within 1 business day of the purchase, excluding weekends and holidays. Certain sections of the report may...
-
Product Insights
Portugal Contrast Agents Market Share
Contrast Agents (Diagnostic Imaging) Portugal Market Share report provides quantitative market trends within the Diagnostic Imaging therapeutic area. Robust methodologies ensure an accurate overview of the market to deliver a comprehensive and precise market analysis. It incorporates primary sources from both the demand and supply sides. This is an on-demand report that will be delivered upon request. The report will be delivered within 1 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be...